These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

65 related articles for article (PubMed ID: 2382439)

  • 41. Diabetic microangiopathy: lupus anticoagulant dependent thrombotic tendency in type 1 (insulin-dependent) diabetes mellitus.
    Gargiulo P; Schiaffini R; Bosco D; Ciampalini P; Pantaleo A; Romani B; Arcieri P; Andreani D
    Diabet Med; 1997 Feb; 14(2):132-7. PubMed ID: 9047090
    [TBL] [Abstract][Full Text] [Related]  

  • 42. [Protamine dosage for heparin neutralization in open-heart surgery (author's transl)].
    Shiao K
    Fukuoka Igaku Zasshi; 1974 Nov; 65(11):878-88. PubMed ID: 4477114
    [No Abstract]   [Full Text] [Related]  

  • 43. Anticoagulative effects of the inhaled low molecular weight heparin certoparin in healthy subjects.
    Scheuch G; Brand P; Meyer T; Herpich C; Müllinger B; Brom J; Weidinger G; Kohlhäufl M; Häussinger K; Spannagl M; Schramm W; Siekmeier R
    J Physiol Pharmacol; 2007 Nov; 58 Suppl 5(Pt 2):603-14. PubMed ID: 18204174
    [TBL] [Abstract][Full Text] [Related]  

  • 44. [The content of the PAMG-1 protein that binds insulin-like growth factor I (somatomedin C) in the blood serum of diabetic patients].
    Nazimova SV; Obernikhin SS; Boltovskaia MN; Starosvetskaia NA; Zaraĭskiĭ EI; Fuks BB
    Biull Eksp Biol Med; 1993 Sep; 116(9):302-4. PubMed ID: 7509650
    [TBL] [Abstract][Full Text] [Related]  

  • 45. [Blood coagulation and thrombocyte aggregation in patients with diabetes mellitus after administration of insulin].
    Riabova EG; Kosyrev AB; Svistunova TN
    Sov Med; 1985; (2):18-22. PubMed ID: 3887583
    [No Abstract]   [Full Text] [Related]  

  • 46. [Heparin-dependent diabetogenic factor in the plasma of children with diabetes mellitus].
    Zhukovskii MA; Kudriashov BA; Ul'ianov AM; Shcherbacheva LN; Tarasov IuA
    Pediatriia; 1985 Feb; (2):7-9. PubMed ID: 3991307
    [No Abstract]   [Full Text] [Related]  

  • 47. [A heparin preparation with prolonged effect, heparin prolongatum for intramuscular injection; preliminary report].
    DOLLERUP E; HEIGAARD JJ; HOLTEN C
    Ugeskr Laeger; 1955 Oct; 117(42):1379-81. PubMed ID: 13281957
    [No Abstract]   [Full Text] [Related]  

  • 48. [Physicochemical properties of the diabetogenic factor and its complex with heparin].
    Kudriashov BA; Ammosova IaM; Liapina LA; Ul'ianov AM
    Farmakol Toksikol; 1987; 50(3):49-52. PubMed ID: 3609278
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Experience with the intramuscular administration of heparin preparations; a comparison between aqueous and retard heparin.
    FANTL P; EBBELS L
    Australas Ann Med; 1952 Nov; 1(2):135-9. PubMed ID: 13008902
    [No Abstract]   [Full Text] [Related]  

  • 50. Intramuscular aqueous heparin.
    GUBBAY ER; PASH E
    Can Med Assoc J; 1953 Aug; 69(2):105-7. PubMed ID: 13067044
    [No Abstract]   [Full Text] [Related]  

  • 51. Intramuscular administration of heparin.
    BAUER G; BOSTROM H
    Acta Med Scand; 1949 Jan; 136(3):188-98. PubMed ID: 15404964
    [No Abstract]   [Full Text] [Related]  

  • 52. [Intramuscular heparin injections].
    WATTEVILLE H; ROLLE J
    Gynaecologia; 1950 Dec; 130(6):398-9. PubMed ID: 14813549
    [No Abstract]   [Full Text] [Related]  

  • 53. [The role of endogenous heparin in the protection against risk factors causing experimental diabetes].
    Kudriashov BA; Ul'ianov AM; Tarasov IuA
    Vopr Med Khim; 1989; 35(6):80-2. PubMed ID: 2629244
    [TBL] [Abstract][Full Text] [Related]  

  • 54. [Natural diabetogenic factor].
    Kudriashov BA
    Sov Med; 1989; (7):51-4. PubMed ID: 2678523
    [No Abstract]   [Full Text] [Related]  

  • 55. [Recovery of the anticoagulation system function in patients with insulin-dependent diabetes by neutralization of the activity of diabetogenic factor].
    Kudriashov BA; Balabolkin MI; Ul'ianov AM; Liapina LA; Levitskaia ZI
    Vopr Med Khim; 1990; 36(3):79-81. PubMed ID: 2382439
    [TBL] [Abstract][Full Text] [Related]  

  • 56. [Complex-formation of heparin with the plasma diabetogenic factor].
    Kudriashov BA; Liapina LA
    Vopr Med Khim; 1986; 32(2):64-5. PubMed ID: 3705518
    [TBL] [Abstract][Full Text] [Related]  

  • 57. [C-peptide, diabetogenic factor and the blood anticoagulating system in patients with the insulin-dependent type of diabetes mellitus before and after heparin therapy].
    Balabolkin MI; Kudriashov BA; Levitskaia ZI; Liapina LA; Ul'ianov AM
    Probl Endokrinol (Mosk); 1990; 36(1):25-8. PubMed ID: 2330356
    [TBL] [Abstract][Full Text] [Related]  

  • 58.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 59.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 60.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.